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Abstract 
 
The main objective of this article is to highlight the new trends that have emerged in the 
enhancement of the HPLC which have given rise to the use of UHPLC. This innovative tool 
is much more reliable and effective as compared to HPLC, in the investigation of many 
chemical compounds. In this article, special insight is given on the changes that have been 
made with regards to both instruments. In this article focus is also placed on the 
implementation of UPLC in various fields of interest, in order to enhance the processes for 
which it is utilized. The pros and cons of the utilization of this method are also addressed in 
this article, along with other relevant characteristics of the same.  
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Introduction 
 
Ultra Performance Liquid Chromatography, or UPLC for short, have been 
investigated and demonstrated high relevance and efficiency in the areas of speed and 
sensitivity of the analysis, as well as in the area of chromatographic resolution. According to 
Swartz et al. (2004), one of its main characteristics lies in the fact that it utilizes very small 
particles and decreases the quantity of solvent required for processing. UPLC is a 
revolutionary tool in the industry that finds its origin in High Performance Liquid 
Chromatography (HPLC). Van Deemter et al. (1956) highlights the fact that the main 
modification made in the development of UPLC lies in the size of the materials or particles 
used during the process of separation.  
 
The main idea of HPLC is based on the fact that the efficiency and resolution are enhanced 
with a reduction in the size of the particulate matter utilized. There is a remarkable increase 
in efficiency as the size of particles fall below 2.5 micrometres, and unlike the deductions 
made from the conventional Van Deemter equation, the process is not hampered by the 
increase in flow rates or in the linear velocity of the mobile phase. (Van Deemter et al, 
1956) The overall analysis shows that the use of peak intensity, velocity and particles of 
smaller dimensions can all lead to the achievement of new and improved results. This 
concept is exactly what defines the principle behind the development of Ultra Performance 
Liquid Chromatography. Zhou et al (2005) points to the fact that the conventional procedure 
of High Performance Liquid Chromatography (HPLC) is recognized for possessing many 
beneficial characteristics that include user friendliness, strength, modifiable sensitivity and 
adequate discrimination.  
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On the other hand, one of the major backdrops of this procedure is the low efficacy rate in 
comparison to similar procedures such as capillary electrophoresis or gas chromatography. 
The main reason behind this backdrop is due to the physical state of the particles; that is, the 
particles used in HPLC are found in a liquid state and so the coefficients of diffusion are 
relatively lower in comparison to the other procedures. As proposed by (Van Deemter et al., 
1956), the equation illustrates that a reduction of particle size enhances the efficiency. 
Nevertheless, this process occurs at the expense of a build-up of retrograde pressure which 
contradicts the pressure limits of the HPLC instruments of 400 bars. As a result, the 
contradictions arising due to the pressure increase and efficiency have been otherwise 
resolved with the use of shorter columns and particles of approximately 2 micrometres in 
size. This solution has been adopted to counterbalance the low efficiency rates at a reasonable 
load per analysis during the use of the HPLC system.  
The efficiency of the HPLC system can be further enhanced by increasing the temperature of 
the system and by the utilization of larger columns.  
Use of the UPLC system 
 
(Gerber et al., 2004) concurs with the ideas of the use of temperature and size of the 
columns, as ways to increase the efficiency of the HPLC system.  An increase in temperature 
would increase the kinetic energy of molecules and allow them to move further away from 
each other, thereby decreasing the viscosity of the column particles and increasing the linear 
velocity of the mobile phase.  In addition, the use of larger (Monolithic) columns, with the 
inclusion of a matrix that supports and allows easy flow of particles, can significantly reduce 
the build-up of resistance within the column, thereby leading to an overall reduction in the 
retrograde pressure build-up.  
 
7 | P a g e  
 
Principle 
 
The main principle involved in the utilization of Ultra Performance Liquid Chromatography 
is that of the addition of smaller particles of less than 2 micrometres in a stationary phase, as 
contrasted with the use of larger particles in the High Performance Liquid Chromatography. 
According to (Swartz et al., 2005), the main idea that regulates this modification is based 
upon the equation proposed by Van Deemter. In this equation, the association between the 
parameters of linear velocity and plate height are closely analysed. The graphical 
representation of this equation is guided by a total of three parameters found in the equation. 
The main principle of the equation is that the linear velocity improves more significantly with 
the utilization of smaller-sized particles as compared to larger ones.  
The equation can be represented as follows: 
                                                          H=A+B/v+Cv………………… (1) 
In this equation, the constants are represented by the letters A, B and C. v represents the linear 
velocity. The constant A is not influenced by velocity and it signifies the “eddy” mixing of 
particles. The value of constant A decreases, with a reduction in particle sized and an increase 
in uniformity. The second constant B corresponds to the normal trend of molecules to diffuse. 
This is also referred to as the axial diffusion and it is closely related to the liner velocity in 
that its level of significance and influence is inversely proportional to the flow rate. The 
constant C is used to depict the resistance associated with the process of separation. This 
particular type of resistance is referred to as kinetic resistance, and it is formally defined as 
the delay that occurs in the alternating movements between the gaseous state and the 
stationary phase. The relationship is such that an increase in gas flow would lead to an 
increase the lag time of the molecules in the stationary phase relative to those in the mobile 
phase. As a result of this analogy, it is evident that the constant C shares a directly 
proportional relationship with the flow rate v. (Wu et al., 2001) 
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Taking into consideration the aforementioned, it is clearly visible that the efficacy in 
processing the materials can be significantly enhanced, together with the agility with which 
the analysis can be performed, without hampering the overall progress of chromatography. 
The development and launching of UPLC has sparked the need for the generation of novel 
equipment for carrying out liquid chromatography. This equipment would exploit the benefits 
associated with the achievement of the separation process at significantly higher pressure 
levels in comparison to that which is used in the HPLC. With this in mind, it is clear that 
there is a directly proportional relationship between the efficiency and the length of the 
column used, while the opposite is true about the size of the particles used; that is, the smaller 
the particles, the greater is the efficiency of the system. (Swartz M. E., 2005).  
In the final analysis, it is feasible to decrease both the length of the column and the size of the 
particles used, while maintaining adequate resolution as required. Wu et al. (2001) achieved 
significant results in the implementation of UPLC for the discovery of metabolites of drugs 
that were otherwise difficult to trace. In their study, the authors recorded significant success 
with regards to the resolution of results and the method of separation.  
Sample injection 
 
   
 
Fig1. Sample injection system (Swartz M. E., 2005) 
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Swartz (2005) highlights the importance of the manner in which the sample for analysis with 
UPLC is injected. One of the backdrops of the commonly used injection valves (see fig.1) is 
the lack of special design and structure to withstand the action of rising pressures within the 
system. In order to guarantee that the column is carefully guarded against the extreme 
changes in pressure, the process of introducing the samples must carried out in a manner so 
as to prevent the rapid injection of large quantities of samples, as well as the volume that is 
moved by the system should be kept at a minimum level, so as to avoid the spreading of 
bands.  
 
According to Swartz (2005), in order to adequately exploit the benefits of a speedy analysis 
with UPLC, it is essential to consider a rapid injection run time. This overall requirement 
signifies that a greater sample capacity is also needed. The sensitivity of the system can be 
further enhanced by administering small quantities of sample with very little leftover 
particles. In the case of organic sample, the same can be directly introduced into the system.  
UPLC Columns 
 
Fig2. UPLC columns (Swartz M. E., 2005). 
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Swartz (2005) also supports the concept that an increase in the efficiency of the UPLC 
system, in which a column supporting packed particles of 1.7 micrometres in size, results in 
the enhancement of the overall resolution. A bonded stage is essential for the disintegration 
of the sample. The separation of samples via UPLC can be done with the utilization of the 
phases such as (see fig.3), ACQUITY UPLC BEH Shield RP18: in this case a polar group 
column is installed. ACQUITY UPLCTM BEH C18 and C8: this consist of columns 
comprising of straight chain alkyl groups ACQUITY UPLC BEH Phenyl: in this phase, the 
phenyl group is bonded to the silyl group with the aid of a C6 alkyl group.  
 
As can be clearly observed, the different columns provide a distinct mixture of bonding and 
reaction with the compounds being analyzed. The most commonly known and widely utilized 
columns are the ACQUITY UPLC BEH C18 and C8 types. These columns are frequently 
used in UPLC separation analysis because of their broad pH spectrum. They are characterized 
by possessing multiple ligand attachment properties that give rise to lower chemical stability 
in more acidic environments. The combination of this characteristic with the higher stability 
of the BEH particle measuring 1.7 micrometres provides the broad spectrum of pH which 
facilitates coverage for the analysis and separation of the sample.  
 
On the other hand, ACQUITY UPLC BEH Shield RP18 columns are made with the objective 
of working hand in hand with the ACQUITY UPLC BEH C18 and C8 phases. With regards 
to the ACQUITY UPLC BEH Phenyl columns, a trifunctional bond is established between 
the phenyl ring and the silyl functionality. This ligand ensures that column lifetimes are 
extensive and that the peak shape remains in optimal conditions. With the formation of a 
unique structural arrangement on the small particle, the process of selectivity is enhanced.  
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Fig3. ACQUITY UHPLC BEH Column chemistries (Lippert et al., 1997) 
 
The column utilized is designed with an internal diameter of 2.1 mm and to obtain the most 
optimum level of resolution, a column of 10 cm is required. The same may be shortened to 5 
cm in length for a faster separation and better utilization of samples. One of the backdrops of 
using smaller particles (1.7 micrometres) is the poor capacity of the detector to record smaller 
peaks with shorter durations (<1 second). This problem can be effectively controlled by 
modifying the sensitivity levels and sampling rate of the detector. In accordance to the 
method of detection employed, the sensitivity levels must be much higher when using UPLC 
as compared to that of separations with HPLC. 
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The ACQUITY UHPLC instrument comprises of two main components with their 
respective sub-components. These include the following: 
Binary solvent manager: driven by two flow serial pumps that aid in the creation of a parallel 
gradient.  
Sample manager: this component includes the column heater, detector, as well as an optional 
sample organiser.  
Within the system, a choice can be made from a selection of four solvents. This is easily 
facilitated with the use of values that have been incorporated with the design of the system. 
The pressure limit reaches approximate values of about 1000 bars and this further enhances 
the ability to utilize particles below 2 micrometres in diameter. Other novel functions are 
available in the sample manager. The injection of samples in a pressurized manner permits 
the maintenance of a low distribution rate and the process is done in an automated fashion 
with the regulation of special transducers. In addition, a special sampling method (needle-in-
needle) is employed with sensors to enhance the quality and precision of the process. The 
process of carryover is controlled with the use of a washing method. This wash method can 
vary in accordance with cycle time. Optional plate formats can be fitted into the system. A 
total of 22 plates can be used to inject samples with the optional sample organizer. The 
column heater can provide maximum temperatures of 65°C and the same is regulated by the 
sample manger. The closeness of the source inlet to the column outlet facilitates a reduction 
in the unwanted spreading of samples.  (Lippert et al., 1997). Special detectors, equipped 
with advanced electronic technology, are utilized for detecting the components of a sample. 
Given the limitations of the conventional detectors, the introduction of more sophisticated 
technology provides a solution for proper detection of samples.  
In the case of the ACQUITY Tuneable UV/Visible detector, a light guided flow cell similar 
to an optical fibre, is utilized. This permits the effective transmission of light down the flow 
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cell.  Adequate wiring and routing of the necessary tubing and other connections are 
established, in order to ensure that the rate of dispersion remains low, as well as to exploit the 
benefits of leak detectors. (Swartz M. E., 2005) 
 
Difference between HPLC and UPLC assays 
 
Fig4. Difference between HPLC and UPLC assays (Chestnut S.,Salisburg 
J,.2007)  
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Advantages 
Reduces run time while augmenting the sensitivity, Guarantees the selectivity, sensitivity, 
and dynamic spectrum of the analysis of light chromatography. Manages and keeps the 
resolution performance in check. Widens the range of Multiresidue Methods, The ability of 
UPLC to rapidly resolve problems including the quantification of power related and unrelated 
compounds. Relatively quicker analysis using smaller particles, Reduction in cost of 
operation. Reduction in the use of solvent. Facilitates a reduction in the cycle time with a 
corresponding increase in productivity. Augments rate of conversion of samples into 
processed material. This further enhances productivity and guarantees consistency. Ensures 
that the analysis of samples occur in a real – time fashion in line with the manufacturing of 
products. Ensures that the final product is delivered with the expected quality. (Chestnut 
S.,Salisburg J,.2007)  
 
Fig 5.  Difference between UHPLC and HPLC run time(Chestnut S.,Salisburg 
J,.2007)  
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Disadvantages 
The use of higher pressure levels signifies that more attention is needed to ensure that the 
column remains functional. The columns are also subjected to a shorter life span.   
Tubing Slippage 
 
 
Fig6.  Tubing slippage (Chestnut S., Salisburg J., 2007) 
Another disadvantage of this system is its ability to succumb to tubing slippage. This is due 
to the high pressures under which the system operates, associated with pressurized injection, 
which further stresses the tubing. The fittings are shaped in such a way that the tubing is kept 
in place in areas of the system that are prone to high pressures. This design strategy can be 
undesirably opposed with the flow of the fluid throughout the system. The displacement of 
the tubing can lead to the build-up of dead space and the lowering of the efficiency rate of the 
system. Due to the gradual movement of tubing, the process may go unnoticed and the 
detection of the same may be very difficult. This can further lead to the degeneration of the 
equipment. (Chestnut S.,Salisburg J,.2007)  
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Tubing ID Compression 
 
Fig7. ID compression (Chestnut S., Salisburg J., 2007) 
 In order to reduce the possibility of tubing slippage (see fig.6), designers have 
resorted to the use of metallic parts in substitution of the tubing. Nevertheless, the use of 
metal also carries certain disadvantages. High pressures tightening torque, needed to ensure 
that the system is properly sealed, can significantly compress the path and lead to an 
unwanted reduction in the flow. This can further lead to an increase in retrograde pressures, 
clogging and turbulence in the flow of liquid. The process is similar to that of tubing slippage 
in that the diagnostic phase is very difficult.  
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Fig8. Galling (Batts J., 2010) 
 
 
Apart from the possibility of tubing compression, the torque needed to carefully mount the 
metal part properly can result in ripping of the material. This process is also referred to as 
galling and the same may render the receiving port useless. There are instances in which the 
severely damaged port may seal to other parts of the coupled arrangement and hinder the 
repair of the same. Damage may also extend to the conical region of the equipment.  (Batts 
J., 2010) 
 
Applications of UPLC  
Compound Library Maintenance  
It is essential to screen libraries containing a wide range of chemical compounds, in order to 
certify their characteristics and potential for pharmaceutical usage. The certainty of the 
synthesis of the target compound must be attested.  The availability of a complete apparatus 
is required in the area of testing pharmaceutical ingredients. The same would take into 
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consideration all of the necessary steps, from the processing of the specimen up to the results, 
while the more complex analysis would be carried out by other experts. The union of UPLC 
with special software can facilitate the task of chemists who are seeking to discover or 
identify certain chemical compounds within a specified timeframe. (Patil et al., 2011)  
Open Access  
 Laboratories that are dedicated to carrying out analytical studies must seek the 
optimum efficiency since a high level of results is anticipated and the processes involved are 
very challenging. As a result of this, special systems, such as the UPLC/MS systems have 
been developed to ensure that the operations and investigations in the area of medicinal 
chemistry are properly carried out.  
 
Forced Degradation Studies  
The study of the stability of compounds is of vital importance in the pharmaceutical industry, 
since it determines the effect that such compounds may have on life. The testing of such 
stability is required before approval of the pharmaceutical compounds can be obtained. This 
process serves the function of determining beforehand, the way in which drugs would change 
with time and when they interact with the surroundings. The information obtained from 
testing stability would further determine particular characteristics such as the conditions 
under which a product must be stored, as well as the period during which the product can be 
consumed. 
 
 Further testing is also carried out under conditions that simulate more aggressive 
environments. This process is referred to as stress testing or forced degradation and it is one 
of the earliest investigations that are carried out during the development of certain 
pharmaceutical products. The results of such extreme tests aids in the discovery of the 
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metabolites or bi-products that are derived from reactions and this permits the development 
of methods directed towards the maintenance of drug stability, should the situation arise. 
Traditionally, HPLC or other similar techniques have been employed in the monitoring of 
this process. Nevertheless, these methods carry the disadvantages of narrow resolution 
spectrum and requiring prolonged periods. The combined utilization of UPLC together with 
other special techniques, such as photo diode array and MS, facilitates a wider range of 
results and provides faster and more accurate readings. This would guarantee that all products 
of degeneration are obtained and that the necessary steps are taken to counteract the same. 
The end result is the development of a more complete and chemically stable product with 
greater knowledge of the same. (Patil et al., 2011) 
 
Manufacturing / QA / QC  
Many factors must be considered when developing new products. In order to ensure that the 
highest quality of products are attained, special considerations must be taken into account to 
ensure that the materials used as substrate are pure as possible. This process is known as 
quality assurance and control and it helps with ensuring that the final products meet the basic 
stipulated guidelines. The continuation of careful regulation of the stability of products and 
materials constitutes an essential part of quality assurance and control. UPLC is effectively 
exploited in the completion of the same. The maintenance of consistency in the production of 
goods of good standard is necessary for the development of trustworthiness of marketing 
companies and this provides the opportunity for continued production without constant need 
for regular auditing.  (Patil et al., 2011) 
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Method Development / Validation  
 Validation refers to the provision of evidence, with a high level of certainty, that a 
product meets all of the requisite conditions stipulated by the evaluating body. This process is 
regulated by the Food and Drug Administration. The procedure can be very lengthy given the 
number of factors to be taken into consideration. The utilization of UPLC reduces the lengthy 
periods and increases the throughput, among other benefits. The process can also be easily be 
applied across a greater range of projects involving separation of chemicals. UPLC 
conditions the speedy creation of methods: this is due to the fact that the time required for 
sample analysis, using UPLC, is significantly lesser than that which is required for other 
procedures of separation. As a result, products can be generated and certified at a faster rate.  
(Patil et al., 2011) 
 
Certain components of UPLC play a crucial role in provided the requisite data. These 
components includes: UPLC columns: a broad spectrum of pH and temperatures can be used 
given the characteristics of the UPLC Calculator: this system is customized to convert from 
conventional methods to the current ultra-performance method. Column Manager: this 
component regulates a very vast temperature spectrum and facilitates the utilization of 
conventional procedures (HPLC) prior to the use of UPLC.  
Impurity Profiling  
The measuring of chemical compounds and the associated impurities, even before product 
development is initiated, is very important in the area of drug creation. High resolution 
chromatography is a key element for the profiling of any impurities found in chemicals. The 
capacity of the procedure to point out even the lowest levels of impurities translates into great 
repercussions for pharmaceutical companies. The reason for this lies in the fact that purer 
versions of products can be produced with better results in their utilization. Two flow cells 
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are utilized in the UPLC PDA Detector systems. These cells allow for maximum flexibility in 
terms of resolution and sensitivity. The processing of information is optimum with the peak 
detection design and routine calculations. The process of identifying drugs and other 
metabolites of the body is possible with the utilization of the combination of UPLC and exact 
mass LC/MS. Fast profiling and identification of impurities can be guaranteed by the 
combination of UPLC and exact mass time-of-flight mass spectrometry. (Patil et al., 2011)
   
Analysis of Natural Products and Traditional Herbal Medicine 
Another application of UPLC is for the analysis of natural products and herbal medicines. 
The understanding of the pharmacological importance of herbs is essential for their screening 
validation, and use. The active components present in these herbs can be quickly analysed 
with the combined use of exact mass MS and UPLC, in association with Marker Lynx 
Software data processing for the statistical analysis of the information obtained. The 
combined use of these procedures aids in the rapid understanding of the action of these 
products on and the way in which they can affect the body. The development of drugs from 
these products can be done using special methods, such as fractionation and purification, in 
collaboration with bio analytical tools. (Patil et al., 2011) 
Some specific Applications of UHPLC in Pharmaceutical Sciences 
1. Ultra performance liquid chromatography serves as a more advanced version of “HPLC 
for the analysis of pharmaceutical compounds”.  Research carried out by Toh D. et al, 
(2010) with regards to the profiling of raw and steamed Panax notoginseng using ultra-high 
performance liquid chromatography/time-of-flight mass spectrometry (UHPLC/TOFMS). 
Results obtained from their analysis showed that the steamed form of the Panax 
notoginseng, unlike the raw form, can employ to enrich blood and improve anaemic 
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conditions, through the stimulation of the creation of new blood cells. The conclusion of the 
study was geared towards the proper utilization of the right form of the herb to achieve the 
desirable effect. In their study, the use of the UHPLC/TOFMS methods reduced the time 
needed to complete the study with maintenance of adequate of peak resolution and minimal 
carry-over effect. 
  2. Another study carried out by Deconinck E. et al. (2012) was centered on the 
“Development and validation of an Ultra High Pressure Liquid Chromatographic method for 
the characterization of confiscated illegal slimming products containing anorexics”. In this 
study, a fully validated UHPLC-DAD method for the identification and quantification of 
pharmaceutical preparations, containing molecules frequently found in illegal slimming 
products was developed.  The methodology involved the utilization of a HT C18-B column 
with a gradient.  The development and validation of the proposed methodology was done 
using an Acquity UPLC™ system. The system included a binary solvent manager, a sample 
manager and a photo diode array detector. The output signal was observed and processed 
using special software. The method used was capable of fully analysing and characterizing 
illegal samples, suspected to contain slimming drugs, in runs of only 10 min. The more the 
use of an ammonium acetate buffer combined with acetonitrile permitted the transfer to a 
mass spectrometer, allowing even a more thorough investigation. The application of this 
method significantly reduced time and solvent consumption with increase efficiency as 
compared to that of the conventional HPLC methods. 
3.  The development of the column technology makes UHPLC a very practical and reliable 
technique for the specific analysis of Vitamin D2 and D3 (see fig.9). With recent advancement 
in LC column packing and the utilization of smaller particles, the process has been exploited 
with significant results.  The changes made in the ultra-performance system facilitate higher 
mobile phase flow rates without affecting the separation efficiency that is achieved using 
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columns packed with larger particles. The UPLC have been used associated with MS in 
routine clinical analysis. The resulting UHPLC-MS combined technique is suitable for 
Vitamin D determination because of its ability to differentiate between 25(OH) D2 and 
25(OH) D3, which is of utmost importance in the monitoring of the vitamin D levels of 
patients being treated with vitamin D2.   
The appreciation of UHPLC-MS in the clinical testing laboratory is due to the developments 
in software and instrument control that facilitates clear chromatographic separation associated 
with the powerful detection and measurement capabilities of mass spectrometry. UHPLC-MS 
provides quick analysis of biological samples since the volume required is small. The 
chromera data systems, facilitates control of both the UHPLC and MS Components of the 
instrument 
 
 
 
 
Fig9.  Structures of Vitamin D2, and Vitamin D3 (Daughterty S., and Green S., 
2011) 
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.  
 
Fig10. Patient sample with separation and detection of 25 hydroxyvitamin D2 
(blue trace), 25-hydroxyvitamin D3, (red trace) and hydroxyvitamin D3-d6 
(purple trace) (Daughterty S., and Green S., 2011) 
 This figure.10 shows the clear peak separation from samples of 25 hydroxyvitamin 
D3, 25 hydroxyvitamin D3-d6 and 25 hydroxyvitamin D2. In comparison to other methods, the 
conditions used for the routine vitamin D testing by UHPLC/SQ MS resulted in highly 
symmetric peaks with a very low run time of only 6 min, illustrating the agility of the 
combined UHPLC-MS procedure.  Ease and speed of analysis did not interfere with the 
detection of trace analytes.  Results showed that patient samples below 4ng/mL 25 
hydroxyvitamin D were detected and quantified without any difficulty.  Therefore, the 
UHPLC-MS is a very precise and advanced technique for detecting and quantifying vitamin 
D levels within the clinical significant range.  The utilization of the combination of improved 
column design, fast chromatographic separations (UHPLC) with robust single quadrupole 
mass spectrometry detectors (MS) and sophisticated data systems is currently resulting in the 
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growing acknowledgement of UHPLC-MS methods as being significantly more useful in bio 
analytical laboratory.  (Daughterty S., and Green S., 2011) 
 
Conclusion 
Thus Ultra Pressure Liquid Chromatography has revolutionized the science of Liquid 
Chromatography and the employment of the same.  This technique has significantly modified 
the manner in which investigation and analysis is done.  The discovery and development of 
UPLC has opened the doors to new insights and uses of chromatography and has reduced the 
workload and difficulties faced by analysts and scientists. Its multiple advantages outweigh 
the backdrops of the system and render it very useful in this era. It has been safely utilized in 
many areas of scientific studies with significant results. It has also demonstrated the capacity 
to be easily coupled with other advance technologies in order to achieve significantly 
improved results. 
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